CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Conference call webcast is scheduled for November 22 at 9 a.m. ET.
SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited , a Singapore-based biopharmaceutical company focused on...

Related Keywords

China ,Japan ,National University Hospital ,Singapore General ,Singapore ,Malaysia ,Peter Choo ,Health Sciences Authority ,Facebook ,Linkedin ,Cytomed Therapeutics Limited ,Cytomed Therapeutics ,Agency For Science ,Nasdaq ,Cytomed Or Company ,Good Manufacturing Practice ,Six Months Ended June ,Public Offering ,Cash Equivalents ,Private Securities Litigation Reform Act ,Amed Therapeutics ,Markets ,